A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris
Condition(s):Acne VulgarisLast Updated:August 17, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Acne VulgarisLast Updated:August 17, 2020Completed
Condition(s):AcneLast Updated:July 19, 2018Completed
Condition(s):Acne VulgarisLast Updated:April 30, 2015Completed
Condition(s):Brittle NailsLast Updated:July 2, 2014Completed
Condition(s):Acne VulgarisLast Updated:May 4, 2017Completed
Condition(s):Acne VulgarisLast Updated:March 1, 2021Completed
Condition(s):Acne VulgarisLast Updated:June 12, 2020Completed
Condition(s):Acne VulgarisLast Updated:August 17, 2018Completed
Condition(s):Acne VulgarisLast Updated:September 23, 2020Completed
Condition(s):Plaque PsoriasisLast Updated:August 29, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.